GlassScriptPhysician profile
Peter F Klein
NPI 1912900036
$9,222.97
in general payments reported to CMS, 2019-2025
17 companies · $184 in 2025
The $184 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,478 · 2020: $94.29 · 2021: $85.71 · 2022: $131 · 2023: $3,077 · 2024: $173 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,072 · Food and Beverage: $362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,071.80 |
| Food and Beverage | $362.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,475.34 | 2019-2025 | Davinci Xi, Da Vinci Surgical System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $146.10 | 2019-2023 | Trulance |
| Takeda Pharmaceuticals U.S.A., INC. | $112.41 | 2020-2024 | Entyvio, Gattex |
| Shire North American Group INC | $84.42 | 2019 | |
| Vioptix INC | $80.68 | 2022 | |
| Ferring Pharmaceuticals INC. | $63.08 | 2019 | |
| Integra Lifesciences Corporation | $39.17 | 2021-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Pacira Pharmaceuticals Incorporated | $38.96 | 2019-2025 | Exparel |
| Braintree Laboratories, INC. | $37.61 | 2019-2020 | |
| Medtronic, INC. | $24.23 | 2024 | Interstim |
| Aimmune Therapeutics, INC. | $21.88 | 2024 | |
| Aroa Biosurgery Incorporated | $19.75 | 2022 | |
| La Jolla Pharmaceutical Company | $17.21 | 2023 | Xerava |
| Vertex Pharmaceuticals Incorporated | $16.75 | 2025 | |
| Mallinckrodt Hospital Products INC. | $16.52 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $15.86 | 2019 | |
| Biom'Up Sa | $13.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Klein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.